The FDA has posted a new Web site that spells out the safety information that has been gleaned from recently launched vaccines and biologics. The agency is using the site to share what safety information it has gathered on a drug 18 months after its approval or after 10,000 people have used it, whichever comes first. The agency plans to scan a broad base of data on adverse events. Report